Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New Promilin Patent Awarded - Nutraceuticals World
Market Updates

New Promilin Patent Awarded

TSI Health Sciences, Missoula, MT, has secured a U.S. patent for its Promilin ingredient, allowing the company to continue to develop the market for this proprietary product, which promotes healthy glucose and insulin utilization. A key provision of U.S. patent 7,338,675, entitled “Fenugreek seed bio-active compositions and methods for extracting same,” involves providing novel compositions and methods for the extraction and separation of bioactive compounds/compositions of 4-hydroxyisoleucine from fenugreek seeds. This unique composition can work either synergistically with insulin, or independently to stimulate GT-4 receptors located on skeletal muscles, to stimulate glucose transport proteins and facilitate the transport of glucose into muscle cells.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters